Palvella Therapeutics (PVLA) Research & Development (2014 - 2026)
Palvella Therapeutics' Research & Development was $12.47 million in Q2 2026, up 143.7% from $5.12 million a year earlier and up 33.6% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Research & Development (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Palvella Therapeutics' Research & Development was $35.46 million through Jun 30, 2026, up 137.7% year-over-year; for FY2025, it was $22.84 million, up 180.2% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
- In earlier years, Research & Development was $8.15 million in FY2024 (-7.3%), $8.79 million in FY2023 (-83.4%), $52.98 million in FY2022 (-20.5%) and $66.66 million in FY2021 (+43.3%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q2 2023.
- Compared with a year earlier, Research & Development has increased for six straight quarters, with growth averaging 151.4% over the last seven quarters.
- The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 314.0%); the worst was Q1 2024 (a decline of 92.7%).
- Per Business Quant data, PVLA's Research & Development in the three quarters before Q2 2026 was $9.33 million (Q1 2026), $7.12 million (Q4 2025) and $6.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | 12.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.47 Mn |
| Mar 31, 2026 | 9.33 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 984,000.00 |
| Dec 31, 2023 | -28.55 Mn |
| Sep 30, 2023 | 9.60 Mn |
| Jun 30, 2023 | 14.33 Mn |
| Mar 31, 2023 | 13.42 Mn |
| Dec 31, 2022 | 13.38 Mn |
| Sep 30, 2022 | 13.59 Mn |
| Jun 30, 2022 | 11.95 Mn |
| Mar 31, 2022 | 14.07 Mn |
| Dec 31, 2021 | 15.36 Mn |
| Sep 30, 2021 | 18.94 Mn |
API Access
Palvella Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();